
Godfrey Pearlson
Professor of Psychiatry and Neuroscience at Yale University and founding director of the Olin Neuropsychiatry Research Center; expert in psychedelics and cannabis neuroscience research.
1
APPEARANCES
1
PODCASTS
012
DEC 30
JAN 6
JAN 13
JAN 20
JAN 27
FEB 3
FEB 10
FEB 17
FEB 24
MAR 3
MAR 10
MAR 17
MAR 24
MAR 31
APR 7
APR 14
APR 21
APR 28
MAY 5
MAY 12
MAY 19
MAY 26
JUN 2
JUN 9
JUN 16
JUN 23
JUN 30
JUL 7
JUL 14
JUL 21
JUL 28
AUG 4
AUG 11
AUG 18
AUG 25
SEP 1
SEP 8
SEP 15
SEP 22
SEP 29
OCT 6
OCT 13
OCT 20
OCT 27
NOV 3
NOV 10
NOV 17
NOV 24
DEC 1
DEC 8
DEC 15
DEC 22
DEC 29
JAN 5
JAN 12
JAN 19
JAN 26
FEB 2
FEB 9
FEB 16
FEB 23
MAR 2
MAR 9
MAR 16
MAR 23
MAR 30
APR 6
APR 13
APR 20
APR 27
MAY 4
MAY 11
MAY 18
MAY 25
JUN 1
JUN 8
JUN 15
JUN 22
JUN 29
JUL 6
JUL 13
JUL 20
JUL 27
AUG 3
AUG 10
AUG 17
AUG 24
AUG 31
SEP 7
SEP 14
SEP 21
SEP 28
Jun 17, 2026
The what and why of psychedelics research - Godfrey Pearlson
1:25
1:33
1:42
1:54
1:08
First of all, let's just give the listeners an idea about how these substances, psychedelic substances in general, are able to influence the way our brain works and maybe why some substances in general can influence our brain activity and some cannot.

Godfrey PearlsonGUEST
Okay, so maybe a useful way to approach that important question is just to start off with some basic definitions.

Godfrey PearlsonGUEST
So there are a number of terms that are Similar and therefore confusing, but let's briefly go through them just to unpack them for listeners.

Godfrey PearlsonGUEST
So if we describe a substance as psychoactive, it just means that it's a chemical that affects perception or mood or consciousness or cognition or behavior, just in a broad sense.

Godfrey PearlsonGUEST
So many substances are psychoactive like alcohol or tobacco or Valium or sleeping pills or antidepressants.
21 MINS LATER
22:38
Could you please elaborate on that? For example, if a person suffering from post-traumatic stress disorder or depression reaches out to their to their psychiatrist and asks for a prescription for medicinal marijuana, what are the factors that a clinician takes into account before deciding whether this particular patient is a good candidate or not?
